TABLE 5.
Funding of dietary supplement research for selected research areas by the NIH in fiscal years 2009 and 20101
| Research area | NIH funding | NIH dietary supplement funding2 |
| $, millions | % | |
| Cancer | 184.8 | 61.0 |
| Cardiovascular disease | 143.7 | 47.4 |
| Women’s reproductive health | 117.3 | 38.7 |
| Immune function | 95.7 | 31.6 |
| Central nervous system | 94.0 | 31.0 |
| Cellular, enzymatic, or molecular mechanisms | 70.7 | 23.3 |
| Pediatric topics | 47.6 | 15.7 |
| GI function | 45.8 | 15.1 |
| Musculoskeletal system | 44.9 | 14.8 |
| Obesity | 40.2 | 13.2 |
| Diabetes | 37.3 | 12.3 |
| Nutrient requirements/metabolism | 36.7 | 12.1 |
| Respiratory system | 33.6 | 11.0 |
| Cognitive function | 30.4 | 10.0 |
| Aging | 26.2 | 8.6 |
| Addictions | 9.6 | 3.1 |
| Antioxidant function | 7.6 | 2.5 |
1
Source: Computer Access to Research on Dietary Supplements (CARDS) database (6). GI, gastrointestinal.
2
If applicable, grants were assigned to multiple categories. Therefore, a grant could have been counted multiple times.